Skip to main content

UBS Group AG

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in AQST

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,907,000
-$19,458 QoQ
Shares Held
458,414
-1.2% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 185 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in AQST Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. AQST ranks #36 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AQST

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,907,000 458,414
2026-03-31 $1,926,458 464,207
2025-12-31 $1,915,033 296,445
2025-09-30 $2,789,609 499,036
2025-06-30 $1,195,782 361,264
2025-03-31 $911,554 314,329
2024-12-31 $1,497,204 420,563
2024-09-30 $451,631 90,689
2024-06-30 $70,298 27,038
2024-03-31 $8,520 2,000
2023-12-31 $4,625 2,290
2023-03-31 $4,268 3,744
2022-09-30 $10,609 9,068
2022-06-30 $265 415
2022-03-31 $2,163 829
2021-12-31 $7,620 1,959
2021-09-30 $43,600 10,000
2021-06-30 $55,818 14,060
2021-03-31 $73,704 14,174
2020-12-31 $127,164 23,769
2020-09-30 $68,455 14,100
2020-06-30 $185,073 38,081
2020-03-31 $42,021 19,188